As part of the Strafford Publications’ webinar series, Finnegan partners Adriana Burgy, Tom Irving, Jill MacAlpine, and Barbara Rudolph will provide guidance on recent Orange Book developments and implications for patent prosecution, listing, and litigation. They will also examine Form 3542 and pitfalls to avoid. For more information, or to register, please see Strafford’s website.
Tags
drugs, Food and Drug Administration (FDA), Manual of Patent Examining Procedure (MPEP), Obviousness (35 USC § 103), Orange Book, patent application, Patent Trial and Appeal Board (PTAB), patentability, United States Court of Appeals for the Federal Circuit (CAFC), United States Patent and Trademark Office (USPTO)
